Norges Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-161,000
| Closed | -$489K | – | 1840 |
|
|
2024
Q4 | $489K | Buy |
+161,000
| New | +$489K | ﹤0.01% | 1795 |
|
|
2024
Q3 | – | Sell |
-161,000
| Closed | -$414K | – | 1897 |
|
|
2024
Q2 | $414K | Hold |
161,000
| – | – | ﹤0.01% | 1891 |
|
|
2024
Q1 | $792K | Hold |
161,000
| – | – | ﹤0.01% | 1813 |
|
|
2023
Q4 | $1.42M | Hold |
161,000
| – | – | ﹤0.01% | 1828 |
|
|
2023
Q3 | $1.85M | Hold |
161,000
| – | – | ﹤0.01% | 1842 |
|
|
2023
Q2 | $4.07M | Hold |
161,000
| – | – | ﹤0.01% | 1767 |
|
|
2023
Q1 | $5.19M | Hold |
161,000
| – | – | ﹤0.01% | 1741 |
|
|
2022
Q4 | $2.97M | Buy |
+161,000
| New | +$2.97M | ﹤0.01% | 1911 |
|